Quantcast Cold Antibodies - Immunohematology and Blood Banking II

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
(2)  Variation in the strength of the antigen. Some antigens that do not show
dosage in terms of zygosity may vary in strength on cells from different individuals. The
antigens most notable for this are P1, Sda, Lea, Leb, and I. Sometimes diminished
antigenic strength can be related to disease, or to the length of time that the cell
suspension has been stored.
1-38. COLD ANTIBODIES
a. Background. These antibodies react best at room temperature (RT) and
below, while reactions after 37C incubation and with AGT are negative or weakly
positive. Some cold agglutinating antibodies, notably anti-I, anti-lH, and anti-H, bind
complement following the antigen-antibody interaction at low temperatures; subsequent
37C incubation may cause the antibody to elute from the cell, but the attached
complement remains, and produces a positive reaction when antiglobulin serum is
added. An antibody displaying these characteristics in the screening test or in
crossmatches should be tested at 18C and/or 4C with specially selected cells, such as
cord cells.
b. Cold Autoabsorption to Remove Cold-Reactive Autoantibody.
(1)  When a strong, cold, autoantibody is present, meaningful
antibody-screening and compatibility studies cannot be done until the autoantibody is
removed. This can be done with the patient's untreated or enzyme-treated cells.
Enzyme pretreatment results in faster antibody removal, and is more effective with very
high-titered autoantibodies. Untreated autoabsorption is usually satisfactory for
removing low-level activity.
(2)  Some alloantibody may also be removed by the Matuhasi-Ogata
phenomenon, or by transfused cells in the circulation. In recently transfused patients,
when autoabsorption might result in removing alloantibody activity, the
antibody-screening test and compatibility tests should be done at 37C, using serum
from a blood sample clotted at 37C and kept at that temperature until the serum is
removed. This permits detection of antibodies active at 37C, and by AGT, but not
cold-reactive alloantibodies.
(a) STEP 1. Obtain a blood specimen from the patient. At the bedside
draw two specimens of blood, one in a tube immediately placed in ice, the other in a
tube containing anticoagulant and incubate it at once at 37C. To do this, bring a
heated block, water bath, or vacuum jug of 37C water to the patient's bedside. The
tube may also be transported in an inside pocket.
(b) STEP 2. Allow the first (iced) specimen to clot in the refrigerator.
Separate the serum by centrifuging in ice-filled cups or a refrigerated centrifuge.
Immediately remove the serum from the clot.
MD0846
1-52



Medical News
The promise and peril of genome sequencing newborns
Even though doctors and researchers have made great strides in...
scopeblog.stanford.edu
The promise and peril of genome sequencing newborns
Even though doctors and researchers have made great strides in...
scopeblog.stanford.edu
The science and practice of people-centerd health systems
A unique collection of studies exploring the theme of the...
medicalxpress.com
How to protect health workers in conflicts and crisis
Recruiting health workers with high levels of internal motivation is...
medicalxpress.com
People prone to delusions make rushed decisions, research shows
People who are prone to delusions gather insufficient information before...
medicalxpress.com
Despite genetic advances, detection still key in breast cancer
Just a few years before the launch of the first...
scopeblog.stanford.edu
Despite genetic advances, detection still key in breast cancer
Just a few years before the launch of the first...
scopeblog.stanford.edu
Liberia's Sirleaf sees signs of Ebola 'stabilisation'
Liberian President Ellen Johnson Sirleaf said Wednesday the Ebola outbreak...
medicalxpress.com
Study pinpoints microRNA tied to colon cancer tumor growth
Researchers at the University of Minnesota have identified microRNAs that...
medicalxpress.com
Ebola: Dallas Case Inevitable -- Experts
(MedPage Today) -- Widespread disease is regarded as highly unlikely....
medpagetoday.com
Delayed introduction to gluten appears not to prevent celiac disease in at-risk infants
How can parents with the autoimmune disorder celiac disease prevent...
medicalxpress.com
B and T cell-targeting drug ameliorates chronic graft-versus-host disease in mice
Hematopoietic stem cells (HSCs) can differentiate into all types of...
medicalxpress.com
Teen pregnancies, abortions plunge with free birth control
Teens who received free contraception and were educated about the...
medicalxpress.com
Clinical trial evaluates heterologous prime/boost regimens in preventative HIV vaccination
Almost 40 million people worldwide live with HIV/AIDS, with an...
medicalxpress.com
Access, Education Can Knock Down Teen Pregnancy
(MedPage Today) -- Free contraceptives first step in curbing teen...
medpagetoday.com
Sunshine Act Database Debuts to Skepticism
WASHINGTON (MedPage Today) -- Medical community has little good to...
medpagetoday.com
Montmorency tart cherry juice lowered blood uric acid levels and a marker for inflammation
Tart cherries have long been researched for their association with...
medicalxpress.com
Obesity tied to higher cancer risk for CRC survivors
(HealthDay)—Colorectal cancer (CRC) patients who are overweight or obese when...
medicalxpress.com
What email does to your brain
Have you ever been in a situation in which you...
scopeblog.stanford.edu
What email does to your brain
Have you ever been in a situation in which you...
scopeblog.stanford.edu
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +